New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareVesilute vs Semax

Vesilute vs Semax

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Vesilute
Cognitive Enhancement
Semax
Summary
Vesilute is a tetrapeptide bioregulator (Lys-Glu-Asp-Leu) developed by Professor Vladimir Khavinson, tissue-specific for the retina and visual system. It supports retinal cell function, promotes normalization of photoreceptor protein synthesis, and is studied for age-related macular degeneration (AMD), retinal aging, and vision preservation in the elderly.
Semax is a synthetic heptapeptide derived from ACTH developed in Russia. It is a potent nootropic that enhances memory, focus, and provides neuroprotection. Approved in Russia for cognitive disorders, stroke recovery, and traumatic brain injury.
Half-Life
Short (minutes); sustained gene-regulatory effects
Minutes (but effects persist for hours via BDNF induction)
Admin Route
SubQ, Oral
Intranasal, SubQ
Research
Typical Dose
10 mg per day
0.25–1 mg (250–1000 mcg)
Frequency
Daily for 10–30 days
1–2 times daily
Key Benefits
  • Supports retinal photoreceptor cell function and survival
  • May slow progression of age-related macular degeneration
  • Reduces retinal cell apoptosis from oxidative stress and aging
  • Anti-aging effects on retinal pigment epithelium
  • Potential support in diabetic retinopathy management
  • Preserves visual acuity with aging
  • Complementary to lutein, zeaxanthin, and NAD+ in ocular health protocols
  • Enhances memory and learning
  • Improves focus and concentration
  • Increases mental energy and motivation
  • Provides neuroprotection via BDNF and NGF upregulation
  • Reduces cognitive decline
  • May alleviate ADHD symptoms
  • Supports recovery from brain injury and stroke
  • Fast-acting — effects within 30–60 minutes
  • Approved in Russia for cognitive disorders and stroke recovery
Side Effects
  • Generally well tolerated
  • Mild injection site reactions
  • No significant ocular adverse events reported at standard doses
  • Headache (rare, often from higher doses)
  • Anxiety or overstimulation at high doses
  • Sleep disruption if dosed too late
  • Irritability (uncommon)
Stacks With